妊娠期间肝酶水平对出生体重的影响
Qingxiu Li1,2, Mian Pan2,3, Jiayi Chen1,2
1Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, 350004, China.
Maternal and child health journal
|September 5, 2025
概括
孕妇在怀孕期间的肝酶水平,包括胺转移酶 (GGT),与出生体重异常有关. 监测这些酶及其变化可能有助于预防不良胎儿发育结果,如巨和低出生体重 (LBW).
科学领域:
- 产科和妇科
- 产妇和胎儿医学
- 生物化学
背景情况:
- 怀孕期间母亲的健康显著影响胎儿的发育和出生结果.
- 肝酶是母亲新陈代谢状态的重要指标.
- 母体肝酶度与出生体重异常之间的关系需要进一步研究.
研究的目的:
- 检查怀孕期间母亲肝酶水平 (GGT,ALT,AST) 与出生体重异常的风险之间的关系.
- 确定妊娠期间肝酶度的变化是否会影响胎儿的生长参数.
主要方法:
- 预期出生队列研究涉及19003个单独怀孕.
- 测量第一和第三个月的母体胺转移酶 (GGT),氨转移酶 (ALT) 和酸氨转移酶 (AST).
- 分析出生的体重,与妊娠年龄相比较小 (SGA),与妊娠年龄相比较大 (LGA),低出生体重 (LBW) 和宏观体.
主要成果:
- 第一个三个月的GGT与分别由妊娠糖尿病 (GDM) 和妊娠年龄介导的宏观和LBW风险呈正相关性.
- 肝酶水平与LBW和SGA呈现线性关系.
- 怀孕期间肝酶的变化与出生体重,LGA和巨相对应,与SGA风险相对应.
结论:
- 孕妇的肝酶度及其在怀孕期间的变化与胎儿出生体重的不同程度的影响有关.
- 在怀孕期间监测母亲的肝酶可以帮助识别并可能预防胎儿的异常发育.
- 这些发现强调了肝酶监测在产前护理中对优化分娩结果的重要性.
相关概念视频
Teratogenicity
2.7K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K
Factors Affecting Drug Biotransformation: Biological
230
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
230
Liver Physiology
1.1K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
1.1K
Hepatic Drug Excretion: Influencing Factors
214
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
214
Factors Affecting Drug Response: Overview
2.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.3K
Hepatic Drug Clearance: Effect of Protein Binding
284
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
284


